Some people with normal blood pressure have elevated blood pressure when their doctor takes the reading. This phenomenon is known as “white coat hypertension”. But there’s an opposite phenomenon, known as “masked hypertension”, where a person’s blood pressure is normal in a clinical setting, but high the rest of the time. Until now, it has not been clear how prevalent this problem is. A new study by Stony Brook University and Columbia University in New York, however, found that out of a sample of about 888 people nearly 16% had masked hypertension.
People with high blood pressure have an increased risk of suffering from a stroke, heart attack or developing kidney disease, so the ability to accurately measure people’s blood pressure is very important. We have known for many years that 24-hour blood pressure monitoring is more accurate in predicting the risk of having a heart attack or stroke than a one-off measurement at a doctor’s surgery. Twenty-four hour monitoring is done with an portable (“ambulatory”) monitor which takes blood pressure readings every 15 to 30 minutes. These readings are then averaged to give a more accurate assessment of whether someone has hypertension (high blood pressure) or not.
Through the increased use of 24-hour monitoring of people’s blood pressure and the efforts of clinical scientists, the extent of this hidden public health problem is being uncovered. Many people who are considered healthy as a result of having their blood pressure recorded as normal by a healthcare professional, actually have undiagnosed and untreated hypertension.

High blood pressure. American Heart Association
The researchers at Stony Brook University showed that the differences between the clinic and 24-hour measurement of blood pressure was dependent on the age and body mass index of the people being assessed. They showed that the younger people in the study who were of normal weight had higher levels of masked hypertension compared with the older more overweight people. This is an important point for doctors to consider when attempting to accurately identify and measure different people’s blood pressure in the future.
This new study overlaps with the clinical health research our vascular physiology research group is undertaking at Cardiff Metropolitan University. Our group is investigating the link between 24-hour blood pressure and heart function, and brain and kidney blood flow in the general population. As a result of this latest research paper, the information provided has highlighted the importance of routinely measuring 24-hour blood pressure as part of our research work. It will be important for our work to identify people with masked hypertension and understand the impact high blood pressure may have on organs like the brain, eyes and kidneys.
Stress of everyday living
Stresses and pressures associated with everyday living have been proposed as the reasons people may develop masked hypertension. It may be that only through measuring 24-hour blood pressure can masked hypertension be identified.
Some employers offer work-place health assessments, including 24-hour blood pressure monitoring. These sorts of initiatives are invaluable for identifying people with masked hypertension. In addition to identifying the problem, organisations need to put strategies in place to help people deal with stress, manage their blood pressure and reduce their cardiovascular risk.
Dr Barry McDonnell receives funding from the European Commission, Marie Sklodowska-Curie, Horizon 2020, as part of the HIT-LVAD study.
This article was originally published on The Conversation. Read the original article.


GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Why the future of marijuana legalization remains hazy despite high public support
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 



